Novo awaits green light for diabetes drug.
May
Mike
M
D000818:Animals; D003920:Diabetes Mellitus / Q000188:drug therapy*; D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004335:Drug and Narcotic Control; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D051379:Mice; D051381:Rats; D011994:Recombinant Proteins / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D011994:Recombinant Proteins; D052216:Glucagon-Like Peptide 1